2.
HAPS评分预测为无害性AP和非无害性AP的临床结局对比
Comparisons of clinical outcomes between harmless AP and non-harmless AP groups predicted by HAPS [No. of cases (%)]
| Clinical outcomes | HarmlessAP group (n=182) | Non-Harmless AP group (n=521) | P |
| AP: Acute pancreatitis; HAPS: Harmless acute pancreatitis score; APFC: Acute pancreatic fluid collection. | |||
| Transient organ failure Single persistent organ failure |
0 | 93 (17.9) | < 0.001 |
| Respiratory | 0 | 113 (21.7) | < 0.001 |
| Circulation | 0 | 8 (1.5) | < 0.001 |
| Kidney | 0 | 17 (3.6) | < 0.001 |
| Persistent multi-organ failure | 0 | 36 (7.5) | < 0.001 |
| Intensive care unit transfer | 0 | 126 (26.4) | < 0.001 |
| Respiratory support | 0 | 100 (20.9) | < 0.001 |
| Local complication | 8(4.4) | 260 (54.4) | < 0.001 |
| APFC | 7 (3.8) | 170 (35.6) | < 0.001 |
| (ex)pancreatic necrosis | 1 (0.5) | 125 (26.2) | < 0.001 |
| Necrosectomy | 0 | 27 (5.6) | < 0.001 |
| Length of hospital stay | 8(6-11) | 10(7-16) | < 0.001 |
| Mortality | 0 | 23 (4.8) | < 0.001 |